Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 32

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 32
---
 registration statement on Form S-1 (File No. 333-278603), registration statement on Form S-1 (File No. 333-283492) and registration statement on Form S-1 (File No. 333-288816), which were declared effective by the SEC on May 1, 2024, December 5, 2024 and July 29, 2025, respectively, and remain in effect (the “Prior Registration Statements” and, together with the Current Registration Statement, the “Registration Statements”). Such shares consist of up to (i) 12,616,818 Keystone Purchase Shares that we may elect, in our sole discretion, to issue and sell to Keystone, from time to time under the Keystone Purchase Agreements, (ii) 992 Keystone Commitment Shares that have been issued to Keystone as consideration for its execution and delivery of the Keystone Purchase Agreements and (iii) up to 500 Arena Commitment Shares to be issued to Arena as consideration for its execution and delivery of the Arena Purchase Agreement. As of November 24, 2025, there were 21,102,671 shares of Common Stock outstanding and 172,373,412 shares of Common Stock outstanding on a fully-diluted basis. If all of the 729,596,950 shares of our Common Stock offered for resale by the Selling Securityholder under this prospectus were issued and outstanding as of November 24, 2025, such shares would represent approximately 80.89% of total number of shares of our 172,373,412 shares of fully-diluted Common Stock outstanding. 10 The actual number of shares of our Common Stock issuable will vary depending on the then current market price of shares of our Common Stock sold to the Selling Securityholder in this offering and the number of shares of our Common Stock we ultimately elect to sell to the Selling Securityholder under the Keystone Purchase Agreements. If it becomes necessary for us to issue and sell to Keystone under the Keystone Purchase Agreements more than the 729,596,950 shares of our Common Stock being registered for resale under the Registration Statements in order to receive aggregate gross proceeds equal to $25 million under the Keystone Purchase Agreements, we must file with the SEC one or more additional registration statements to register under the Securities Act the resale by Keystone of any such additional shares of our Common Stock we wish to sell from time to time under the Keystone Purchase Agreements, which the SEC must declare effective, in each case before we